Standard BioTools Inc. Payments to Acquire Investments
Standard BioTools Inc. (LAB) reported Payments to Acquire Investments of $137.30 million for the 9-month period ending 2022-09-30, per its 10-Q filed 2022-11-09.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireInvestments · last filed 2022-11-09
- Standard BioTools Inc. payments to acquire investments for the quarter ending 2022-09-30 was $0.00.
- Standard BioTools Inc. payments to acquire investments for the quarter ending 2021-12-31 was $0.00.
- Standard BioTools Inc. payments to acquire investments for the quarter ending 2021-09-30 was $0.00.
- Standard BioTools Inc. payments to acquire investments for the quarter ending 2020-12-31 was $0.00, a 100.00% decline year-over-year.
- Standard BioTools Inc. payments to acquire investments for fiscal 2021 was $0.00.
- Standard BioTools Inc. payments to acquire investments for fiscal 2020 was $0.00, a 100.00% decline from fiscal 2019.
- Standard BioTools Inc. payments to acquire investments for fiscal 2019 was $62.37M, a 4201.38% increase from fiscal 2018.
- Standard BioTools Inc. payments to acquire investments for fiscal 2018 was $1.45M, a 76.90% decline from fiscal 2017.
| Period end | Payments to Acquire Investments 3 month | Payments to Acquire Investments 6 month | Payments to Acquire Investments 9 month | Payments to Acquire Investments 12 month |
|---|---|---|---|---|
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $137.30M 10-Q · filed 2022-11-09 | ||
| 2022-06-30 | $137.30M 10-Q · filed 2022-08-09 | |||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-08 | $0.00 derived: sum of 2 quarters · filed 2022-11-09 | $0.00 10-K · filed 2022-03-08 | |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $0.00 10-Q · filed 2022-11-09 | ||
| 2021-06-30 | $0.00 10-Q · filed 2022-08-09 | |||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-08 | $0.00 derived: sum of 2 quarters · filed 2022-03-08 | $0.00 derived: sum of 3 quarters · filed 2022-03-08 | $0.00 10-K · filed 2022-03-08 |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $0.00 derived: sum of 2 quarters · filed 2020-11-09 | $0.00 10-Q · filed 2020-11-09 | $9.65M derived: sum of 4 quarters · filed 2022-03-08 |
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-07 | $0.00 10-Q · filed 2020-08-07 | $9.65M derived: sum of 3 quarters · filed 2022-03-08 | $17.76M derived: sum of 4 quarters · filed 2022-03-08 |
| 2020-03-31 | $0.00 10-Q · filed 2020-05-11 | $9.65M derived: sum of 2 quarters · filed 2022-03-08 | $17.76M derived: sum of 3 quarters · filed 2022-03-08 | $52.88M derived: sum of 4 quarters · filed 2022-03-08 |
| 2019-12-31 | $9.65M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-08 | $17.76M derived: sum of 2 quarters · filed 2022-03-08 | $52.88M derived: sum of 3 quarters · filed 2022-03-08 | $62.37M 10-K · filed 2022-03-08 |
| 2019-09-30 | $8.11M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $43.23M derived: sum of 2 quarters · filed 2020-11-09 | $52.72M 10-Q · filed 2020-11-09 | $52.72M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-06-30 | $35.12M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-07 | $44.61M 10-Q · filed 2020-08-07 | $44.61M derived: sum of 3 quarters · filed 2021-02-25 | $44.61M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-03-31 | $9.49M 10-Q · filed 2020-05-11 | $9.49M derived: sum of 2 quarters · filed 2021-02-25 | $9.49M derived: sum of 3 quarters · filed 2021-02-25 | $10.76M derived: sum of 4 quarters · filed 2021-02-25 |
| 2018-12-31 | -$1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | -$1.00K derived: sum of 2 quarters · filed 2021-02-25 | $1.26M derived: sum of 3 quarters · filed 2021-02-25 | $1.45M 10-K · filed 2021-02-25 |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08 | $1.26M derived: sum of 2 quarters · filed 2019-11-08 | $1.45M 10-Q · filed 2019-11-08 | $6.28M derived: sum of 4 quarters · filed 2020-02-27 |
| 2018-06-30 | $1.26M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | $1.45M 10-Q · filed 2019-08-07 | $6.28M derived: sum of 3 quarters · filed 2020-02-27 | $6.28M derived: sum of 4 quarters · filed 2020-02-27 |
| 2018-03-31 | $186.00K 10-Q · filed 2019-05-07 | $5.01M derived: sum of 2 quarters · filed 2020-02-27 | $5.01M derived: sum of 3 quarters · filed 2020-02-27 | $5.28M derived: sum of 4 quarters · filed 2020-02-27 |
| 2017-12-31 | $4.83M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | $4.82M derived: sum of 2 quarters · filed 2020-02-27 | $5.09M derived: sum of 3 quarters · filed 2020-02-27 | $6.28M 10-K · filed 2020-02-27 |
| 2017-09-30 | -$2.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | $267.00K derived: sum of 2 quarters · filed 2018-11-06 | $1.45M 10-Q · filed 2018-11-06 | $1.48M derived: sum of 4 quarters · filed 2019-03-18 |
| 2017-06-30 | $269.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08 | $1.45M 10-Q · filed 2018-08-08 | $1.48M derived: sum of 3 quarters · filed 2019-03-18 | $5.49M derived: sum of 4 quarters · filed 2019-03-18 |
| 2017-03-31 | $1.18M 10-Q · filed 2018-05-08 | $1.21M derived: sum of 2 quarters · filed 2019-03-18 | $5.22M derived: sum of 3 quarters · filed 2019-03-18 | $31.26M derived: sum of 4 quarters · filed 2019-03-18 |
| 2016-12-31 | $30.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-18 | $4.04M derived: sum of 2 quarters · filed 2019-03-18 | $30.08M derived: sum of 3 quarters · filed 2019-03-18 | $38.59M 10-K · filed 2019-03-18 |
| 2016-09-30 | $4.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | $30.05M derived: sum of 2 quarters · filed 2017-11-07 | $38.56M 10-Q · filed 2017-11-07 | $51.83M derived: sum of 4 quarters · filed 2018-03-08 |
| 2016-06-30 | $26.05M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | $34.56M 10-Q · filed 2017-08-08 | $47.83M derived: sum of 3 quarters · filed 2018-03-08 | $67.80M derived: sum of 4 quarters · filed 2018-03-08 |
| 2016-03-31 | $8.51M 10-Q · filed 2017-05-09 | $21.78M derived: sum of 2 quarters · filed 2018-03-08 | $41.76M derived: sum of 3 quarters · filed 2018-03-08 | $75.49M derived: sum of 4 quarters · filed 2018-03-08 |
| 2015-12-31 | $13.27M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-08 | $33.24M derived: sum of 2 quarters · filed 2018-03-08 | $66.97M derived: sum of 3 quarters · filed 2018-03-08 | $66.97M 10-K · filed 2018-03-08 |
| 2015-09-30 | $19.97M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | $53.70M derived: sum of 2 quarters · filed 2016-11-09 | $53.70M 10-Q · filed 2016-11-09 | $79.68M derived: sum of 4 quarters · filed 2017-03-03 |
| 2015-06-30 | $33.73M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | $33.73M 10-Q · filed 2016-08-09 | $59.70M derived: sum of 3 quarters · filed 2017-03-03 | $79.58M derived: sum of 4 quarters · filed 2017-03-03 |
| 2015-03-31 | $0.00 10-Q · filed 2016-05-09 | $25.97M derived: sum of 2 quarters · filed 2017-03-03 | $45.85M derived: sum of 3 quarters · filed 2017-03-03 | $117.64M derived: sum of 4 quarters · filed 2017-03-03 |
| 2014-12-31 | $25.97M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-03 | $45.85M derived: sum of 2 quarters · filed 2017-03-03 | $117.64M derived: sum of 3 quarters · filed 2017-03-03 | $132.64M 10-K · filed 2017-03-03 |
| 2014-09-30 | $19.88M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | $91.67M derived: sum of 2 quarters · filed 2015-11-09 | $106.67M 10-Q · filed 2015-11-09 | $109.28M derived: sum of 4 quarters · filed 2016-02-29 |
| 2014-06-30 | $71.79M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10 | $86.79M 10-Q · filed 2015-08-10 | $89.40M derived: sum of 3 quarters · filed 2016-02-29 | $105.61M derived: sum of 4 quarters · filed 2016-02-29 |
| 2014-03-31 | $15.00M 10-Q · filed 2015-05-11 | $17.61M derived: sum of 2 quarters · filed 2016-02-29 | $33.82M derived: sum of 3 quarters · filed 2016-02-29 | $67.03M derived: sum of 4 quarters · filed 2016-02-29 |
| 2013-12-31 | $2.60M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $18.82M derived: sum of 2 quarters · filed 2016-02-29 | $52.02M derived: sum of 3 quarters · filed 2016-02-29 | $59.44M 10-K · filed 2016-02-29 |
| 2013-09-30 | $16.21M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-06 | $49.42M derived: sum of 2 quarters · filed 2014-11-06 | $56.83M 10-Q · filed 2014-11-06 | $64.51M derived: sum of 4 quarters · filed 2015-02-26 |
| 2013-06-30 | $33.21M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-04 | $40.62M 10-Q · filed 2014-08-04 | $48.30M derived: sum of 3 quarters · filed 2015-02-26 | $53.64M derived: sum of 4 quarters · filed 2015-02-26 |
| 2013-03-31 | $7.41M 10-Q · filed 2014-05-12 | $15.09M derived: sum of 2 quarters · filed 2015-02-26 | $20.43M derived: sum of 3 quarters · filed 2015-02-26 | $23.41M derived: sum of 4 quarters · filed 2015-02-26 |
| 2012-12-31 | $7.68M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-26 | $13.02M derived: sum of 2 quarters · filed 2015-02-26 | $15.99M derived: sum of 3 quarters · filed 2015-02-26 | $35.38M 10-K · filed 2015-02-26 |
| 2012-09-30 | $5.34M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-07 | $8.31M derived: sum of 2 quarters · filed 2013-11-07 | $27.70M 10-Q · filed 2013-11-07 | $38.54M derived: sum of 4 quarters · filed 2014-03-12 |
| 2012-06-30 | $2.97M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-07 | $22.36M 10-Q · filed 2013-08-07 | $33.20M derived: sum of 3 quarters · filed 2014-03-12 | $36.03M derived: sum of 4 quarters · filed 2014-03-12 |
| 2012-03-31 | $19.39M 10-Q · filed 2013-05-09 | $30.23M derived: sum of 2 quarters · filed 2014-03-12 | $33.06M derived: sum of 3 quarters · filed 2014-03-12 | $68.90M derived: sum of 4 quarters · filed 2014-03-12 |
| 2011-12-31 | $10.84M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-12 | $13.67M derived: sum of 2 quarters · filed 2014-03-12 | $49.51M derived: sum of 3 quarters · filed 2014-03-12 | $71.38M 10-K · filed 2014-03-12 |
| 2011-09-30 | $2.83M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-09 | $38.67M derived: sum of 2 quarters · filed 2012-11-09 | $60.54M 10-Q · filed 2012-11-09 | |
| 2011-06-30 | $35.84M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-14 | $57.71M 10-Q · filed 2012-08-14 | ||
| 2011-03-31 | $21.87M 10-Q · filed 2012-05-15 | |||
| 2010-12-31 | $0.00 10-K · filed 2013-03-12 | |||
| 2009-12-31 | $0.00 10-K · filed 2012-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| Perspective Therapeutics, Inc. (CATX) | United States | $0.284B | -3.34 |
| Upstream Bio, Inc. (UPB) | United States | $0.284B | -2.42 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| Sagimet Biosciences Inc. (SGMT) | United States | $0.279B | |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |